C6-ceramide-coated catheters promote re-endothelialization of stretch-injured arteries

Vascular Disease Prevention

Volumn 5, Issue 3, 2008, Pages 200-210

  O'Neill, Sean M ^a   Olympia, Dina K ^a   Fox, Todd E ^a   Brown, J Tony ^a   Stover, Thomas C ^a   Houck, Kristy L ^a   Wilson, Ronald ^a   Waybill, Peter ^a   Kozak, Mark ^a   Levison, Steven W ^b   Weber, Norbert ^c   Karavodin, Linda M ^d   Kester, Mark ^a,e  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c State University of New Jersey   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CERAMIDE 1 PHOSPHATE; CERAMIDE DERIVATIVE; CERAMIDE KINASE;

ANGIOPLASTY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETER; ARTERY ENDOTHELIUM; ARTERY INJURY; ARTERY OCCLUSION; ARTICLE; BALLOON CATHETER; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; FIBRIN FORMATION; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; MALE; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SMOOTH MUSCLE FIBER; WOUND HEALING;

EID: 48749124126     PISSN: 15672700     EISSN: None     Source Type: Journal    
DOI: 10.2174/156727008785133809     Document Type: Article

References (36)

1. Elezi S, Dibra A, Schömig A, Kastrati A. Current drug-eluting stents in complex patients and lesions. Minerva Cardioangiol 2006; 54: 5-22.
2. Nielsen TT, Botker HE. Percutaneous coronary intervention in diabetic patients: a problem? Horm Metab Res 2005; 37 (Suppl 1): 83-9.
3. Iijima R, Mehilli J, Schömig A, Kastrati A. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents. Minerva Cardioangiol 2006; 54: 539-55.
4. Agostoni P, Valgimigli M, Abbate A, Cosgrave J, Pilati M, Biondi-Zoccai GG. Is late luminal loss an accurate predictor of the clinical effectiveness of drug-eluting stents in the coronary arteries? Am J Cardiol 2006; 97: 603-5.
5. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al.; BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting vs bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-91.
6. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-41.
7. Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004; 110: 810-4.
8. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006; 255: 2113-24.
9. Charles R, Sandirasegarane L, Yun J, et al. Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries. Circ Res 2000; 87: 282-8.
10. Bourbon NA, Sandirasegarane L, Kester M. Ceramide-induced inhibition of Akt is mediated through protein kinase Czeta: implications for growth arrest. J Biol Chem 2002; 277: 3286-92.
11. Stover T, Kester M. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. J Pharmacol Exp Ther 2003; 307: 468-75.
12. Bourke SL, Kohn J. Polymers derived from the amino acid L-tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol). Adv Drug Deliv Rev 2003; 55: 447-66.
13. Weber N, Wendel HP, Kohn J. Formation of viscoelastic protein layers on polymeric surfaces relevant to platelet adhesion. J Biomed Mater Res A 2005; 72: 420-7.
14. Bowyer JF, Pogge AR, Delongchamp RR, et al. A threshold neurotoxic amphetamine exposure inhibits parietal cortex expression of synaptic plasticity-related genes. Neuroscience 2007; 144: 66-76.
15. Maley D, Mei J, Lu H, Johnson DL, Ilyin SE. Multiplexed RT-PCR for high throughput screening applications. Comb Chem High Throughput Screen 2004; 7: 727-32.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.
17. Merrill AH Jr., Sullards MC, Allegood JC, Kelly S, Wang E. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 2005; 36: 207-24.
18. Fox TE, Han X, Kelly S, et al. Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy. Diabetes 2006; 55: 3573-80.
19. Johns DG, Webb RC, Charpie JR. Impaired ceramide signalling in spontaneously hypertensive rat vascular smooth muscle: a possible mechanism for augmented cell proliferation. J Hypertens 2001; 19: 63-70.
20. Gomez-Munoz A. Ceramide 1-phosphate/ceramide, a switch between life and death. Biochim Biophys Acta 2006; 1758: 2049-56.
21. Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 1993; 178: 2147-56.
22. Olivera A, Buckley NE, Spiegel S. Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts. J Biol Chem 1992; 267: 26121-7.
23. Alewijnse AE, Peters SL, Michel MC. Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. Br J Pharmacol 2004; 143: 666-84.
24. Romiti E, Meacci E, Tani M, et al. Neutral/alkaline and acid ceramidase activities are actively released by murine endothelial cells. Biochem Biophys Res Commun 2000; 275: 746-51.
25. Rajesh M, Kolmakova A, Chatterjee S. Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells. Circ Res 2005; 97: 796-804.
26. Gouaze-Andersson V, Cabot MC. Glycosphingolipids and drug resistance. Biochim Biophys Acta 2006; 1758: 2096-103.
27. Furuya K, Ginis I, Takeda H, Chen Y, Hallenbeck JM. Cell permeable exogenous ceramide reduces infarct size in spontaneously hypertensive rats supporting in vitro studies that have implicated ceramide in induction of tolerance to ischemia. J Cereb Blood Flow Metab 2001; 21: 226-32.
28. Lightle S, Tosheva R, Lee A, et al., Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine-palmitoyl transferase. Arch Biochem Biophys 2003; 419: 120-8.
29. Hammad SM, Taha TA, Nareika A, Johnson KR, Lopes-Virella MF, Obeid LM. Oxidized LDL immune complexes induce release of sphingosine kinase in human U937 monocytic cells. Prostaglandins Other Lipid Mediat 2006; 79: 126-40.
30. Siess W. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta 2002; 1582: 204-15.
31. Li XA, Titlow WB, Jackson BA, et al. High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner. J Biol Chem 2002; 277: 11058-63.
32. Xia P, Vadas MA, Rye KA, Barter PJ, Gamble JR. High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway: A possible mechanism for protection against atherosclerosis by HDL. J Biol Chem 1999; 274: 33143-7.
33. Worgall TS, Johnson RA, Seo T, Gierens H, Deckelbaum RJ. Unsaturated fatty acid-mediated decreases in sterol regulatory element-mediated gene transcription are linked to cellular sphingolipid metabolism. J Biol Chem 2002; 277: 3878-85.
34. Lemos PA, Serruys PW, Sousa JE. Drug-eluting stents: cost vs clinical benefit. Circulation 2003; 107: 3003-7.
35. Kaiser C, Brunner-La Rocca HP, Buser PT, et al.; BASKET Investigators. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET). Lancet 2005; 366: 921-9.
36. Speck U, Scheller B, Abramjuk C, et al. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 2006; 240: 411-8.